A 52-year-old woman with rheumatic mitral stenosis presents with fever (39.2°C), new-onset atrial fibrillation, and a changing cardiac murmur. She reports a dental extraction 2 weeks ago. Blood cultures grow viridans group Streptococcus (penicillin-susceptible, MIC 0.5 µg/mL). Transthoracic echocardiography shows a 15 mm vegetation on the anterior mitral leaflet with moderate mitral regurgitation and no abscess. What is the most appropriate antibiotic regimen?

Explanation

## Antibiotic Selection for Penicillin-Susceptible Viridans Streptococcal Endocarditis ### Organism Identification and Susceptibility **High-Yield:** Viridans group Streptococci are alpha-hemolytic streptococci that are part of normal oral flora. They are the most common cause of subacute endocarditis, especially after dental procedures. **Key Point:** The MIC (minimum inhibitory concentration) of 0.5 µg/mL indicates **penicillin-susceptible** viridans streptococcus (PSVS). This is critical for treatment selection: - **Penicillin-susceptible:** MIC ≤0.06 µg/mL - **Intermediate:** MIC 0.12–1 µg/mL (this case: MIC 0.5 µg/mL falls here) - **Penicillin-resistant:** MIC ≥2 µg/mL ### Treatment Regimens for PSVS Endocarditis | Organism Susceptibility | Regimen | Duration | Notes | |---|---|---|---| | **Penicillin-susceptible (MIC ≤0.06)** | Penicillin G 4 MU IV Q4H alone | 4 weeks | Monotherapy sufficient | | **Penicillin-susceptible (MIC 0.12–1)** | Penicillin G 4 MU IV Q4H + Gentamicin 3 mg/kg/day | 2 weeks penicillin + gentamicin, then 2 weeks penicillin alone | **Total 4 weeks** | | **Penicillin-resistant (MIC ≥2)** | Vancomycin 15–20 mg/kg IV Q8–12H ± Gentamicin | 6 weeks | Prosthetic valve: 6 weeks | **Clinical Pearl:** The addition of gentamicin for 2 weeks in intermediate-susceptibility strains provides synergistic bactericidal activity, allowing the penicillin monotherapy phase to be shortened from 4 to 2 weeks while maintaining efficacy. ### Case Application This patient has: - **MIC 0.5 µg/mL** = intermediate penicillin susceptibility - **Native valve** (rheumatic mitral stenosis, not prosthetic) - **No complications** (no abscess, no perforation) - **Subacute presentation** (2-week history) **Correct regimen:** Penicillin G + gentamicin for 2 weeks, followed by penicillin monotherapy for 2 additional weeks = **4 weeks total**. ### Why Gentamicin? 1. Provides synergy against streptococci (bactericidal enhancement) 2. Broadens gram-negative coverage (though viridans is gram-positive) 3. Shortens duration of dual therapy from 4 to 2 weeks 4. Well-tolerated in 2-week courses; nephrotoxicity/ototoxicity risk is low ### Monitoring Parameters - **Serum creatinine & BUN:** Baseline and weekly (gentamicin nephrotoxicity) - **Audiometry:** If gentamicin course >2 weeks - **Repeat blood cultures:** 48–72 hours after starting antibiotics (should sterilize) - **Echocardiography:** Repeat at 4 weeks to assess vegetation resolution ```mermaid flowchart TD A[Viridans Streptococcus IE]:::outcome --> B{Determine MIC}:::decision B -->|MIC ≤0.06 µg/mL| C[Penicillin G alone<br/>4 weeks]:::action B -->|MIC 0.12–1 µg/mL| D[Penicillin G + Gentamicin<br/>2 weeks]:::action B -->|MIC ≥2 µg/mL| E[Vancomycin ± Gentamicin<br/>6 weeks]:::action D --> F[Then Penicillin G alone<br/>2 more weeks]:::action C --> G[Total: 4 weeks]:::outcome F --> H[Total: 4 weeks]:::outcome E --> I[Total: 6 weeks]:::outcome ``` [cite:Harrison 21e Ch 140]